Robeco Institutional Asset Management B.V. Lowers Position in UnitedHealth Group Incorporated (NYSE:UNH)

Robeco Institutional Asset Management B.V. lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 23.1% in the 4th quarter, Holdings Channel reports. The firm owned 692,143 shares of the healthcare conglomerate’s stock after selling 207,856 shares during the quarter. UnitedHealth Group accounts for approximately 2.1% of Robeco Institutional Asset Management B.V.’s portfolio, making the stock its 5th largest position. Robeco Institutional Asset Management B.V.’s holdings in UnitedHealth Group were worth $364,393,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Richelieu Gestion SA purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at $26,000. CGC Financial Services LLC grew its position in UnitedHealth Group by 1,000.0% during the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 50 shares in the last quarter. NewSquare Capital LLC raised its holdings in shares of UnitedHealth Group by 340.0% in the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 51 shares in the last quarter. LFA Lugano Financial Advisors SA grew its holdings in shares of UnitedHealth Group by 148.1% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after purchasing an additional 40 shares in the last quarter. Finally, O Brien Wealth Partners LLC grew its position in UnitedHealth Group by 36.8% in the fourth quarter. O Brien Wealth Partners LLC now owns 78 shares of the healthcare conglomerate’s stock worth $41,000 after acquiring an additional 21 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.33% of the stock is owned by insiders.

UnitedHealth Group Trading Up 0.6 %

UNH stock traded up $3.36 during mid-day trading on Friday, reaching $524.63. 2,657,396 shares of the stock traded hands, compared to its average volume of 3,305,639. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market capitalization of $482.86 billion, a PE ratio of 32.07, a PEG ratio of 1.52 and a beta of 0.55. The business has a 50-day moving average price of $486.41 and a two-hundred day moving average price of $511.31.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same period last year, the company earned $6.26 earnings per share. The business’s revenue for the quarter was up 8.6% compared to the same quarter last year. Equities research analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a $1.88 dividend. This represents a $7.52 annualized dividend and a dividend yield of 1.43%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s payout ratio is 45.97%.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on UNH. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Monday, May 13th. HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 target price on the stock in a research note on Thursday, April 4th. TD Cowen lowered their price objective on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research note on Wednesday, April 10th. Wells Fargo & Company decreased their target price on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research note on Monday, April 8th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on shares of UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Three equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $570.05.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.